Respiratory infection advice to home care service providers

​​​​​​​​​As of 1 October 2026 

Home care providers should conduct a local risk assessment to guide the implementation of public health measures for preventing, preparing for and responding to acute respiratory infections (ARI).

  • Vaccination: ensure clients are up to date with recommended vaccinations, including COVID-19, influenza and RSV. It is generally safe for COVID-19, influenza and RSV vaccines to be administered on the same day. Clients are encouraged to discuss co-administration of vaccines with their healthcare provider. Please see the  Australian Immunisation Handbook for more information.​
  • Masks: Masks should be worn by staff when the weekly NSW Respiratory Surveillance Report reports:
    • high levels of RSV, influenza or COVID-19, or
    • moderate levels of COVID-19, or
    • moderate levels of both influenza and RSV.
  • Pre-assessment action plans: clients should be encouraged to speak to their doctor about getting pre-assessed for eligibility for antiviral medicines to support timely testing and access.

This advice also applies to people working with the Commonwealth Home Support Programme.

Throughout this document, reference is made to Acute Respiratory Infection (ARI) Guidance.

If you offer aged care services, please refer to the ARI Guidance: Guidance for residential aged care facilities on the public health management of acute respiratory infections (including COVID-19, influenza and Respiratory Syncytial Virus).

If you offer disability care services, please refer to the ARI Guidance: Guidance for Disability Care Facilities on the Public Health Management of​ Acute Respiratory Infections (including COVID-19, Influenza and Respiratory Syncytial Virus).


  • Some home care clients may be at higher risk of severe illness if they develop ARIs. In-home care service providers should maintain vigilance to prevent the introduction of acute respiratory infections (ARI), including COVID-19, influenza, and respiratory syncytial virus (RSV) into a person's home.

    Home care providers are encouraged to make their own decisions on public health measures appropriate to their internal risk assessments. Providers can adapt their public health measures (including mask wearing advice) to suit the specific circumstances within the homes where they deliver services. This includes considering the levels and types of respiratory viruses circulating in the community as published in NSW Respiratory Surveillance Reports and vaccination status of home care clients.

    Staff should ask clients on arrival about ARI symptoms (e.g. cough, runny nose, sore throat, fever or headaches). If staff become aware of a client with symptoms, arrangements should be made for testing of respiratory viruses, or referral to a general practitioner as required.

  • ​

    Providers should encourage clients to meet with their doctor to develop a respiratory virus management plan, which will help to support vaccination, testing and treatment for COVID-19, influenza and RSV.

    • GPs are encouraged to use the Pre-assessment action plan for respiratory infections to establish a plan, ahead of time, for use of COVID-19 and influenza antiviral medicines. There are currently no antivirals against RSV approved for routine use in Australia. 
    • COVID-19 antiviral medicines are available on the Pharmaceutical Benefits Scheme (PBS) for people who meet eligibility criteria.​
    • Administering antiviral treatment as soon as possible after symptom onset or diagnosis may reduce the risk of severe disease and prevent complications such as hospitalisation and death.
    • Influenza antiviral medicines are not currently available on the PBS. However, the Australian Therapeutic Guidelines recommend use of influenza antivirals for certain patient populations. 
  • Providers should ensure they have business continuity plans in place to support adequate staffing coverage. Staff, including students, contractors, volunteers, pathology collectors and therapists should not provide a home care service if they have:

    • Tested positive for COVID-19. Providers should follow the relevant ARI Guidance to determine when it is safe for employees to return to work (see links above).
    • Acute respiratory or influenza-like symptoms.

    Staff exposed to COVID-19

    If a staff member has been exposed to COVID-19, managers should refer to Appendix 2 of the relevant ARI Guidance to support decision-making for when staff can safely return to work, particularly if they are critical to service delivery.

    Testing for respiratory viruses

    It is encouraged that providers provide free RATs to staff to promote testing when there are moderate to high levels of COVID-19 or high levels of influenza or RSV in the community, as indicated by the NSW Respiratory Surveillance Report. Staff with respiratory symptoms should not attend work even with a negative RAT result.

    Mask wearing

    In general, masks should be worn by staff when the NSW Respiratory Surveillance Report reports:

    • high levels of RSV, influenza or COVID-19
    • moderate levels of COVID-19
    • moderate levels of both influenza and RSV.

    Please remember that masks can be removed for staff:

    • while communicating with people who are hearing impaired
    • if wearing a mask creates a risk to health and safety
    • where clear enunciation or visibility of the mouth is essential
    • if they are working alone in an indoor area.

    Staff removing a mask for one of the above reasons can decrease the risk of transmission by physically distancing from others, if appropriate.

    Vaccination for staff

    It is strongly encouraged that home care staff are up to date with all recommended vaccinations, including COVID-19, influenza and RSV.

    The new Aged Care Act 2024 strengthened the requirement for aged care providers to provide access to recommended vaccinations for their staff. For further information, visit Australian Government Department of Health, Disability and Ageing - COVID-19 vaccination for in-home and community aged care recipients, workers and providers and Australian Government Department of Health, Disability and Ageing - Responsibilities of residential aged care providers.

    Staff providing disability home care services are also recommended to stay up to date with other vaccinations to protect themselves and the people they provide care for.

    Providers should review staff vaccination rates and facilitate access to vaccination for those who are due.

  • Vaccination remains the best protection against serious illness and hospitalisation. Aged care clients should receive COVID-19, influenza, shingles, pneumococcal and RSV vaccines, as recommended.

    These vaccines are funded by the Commonwealth for older adults.

    Recommendation* as per Australian Immunisation Handbook

    • COVID-19**
      • For Non-Aboriginal people
        • 75 years and older: 1 dose every 6 months
        • 65-74 years: 1 dose every 12 months
      • For Aboriginal people 
        • ​75 years and older: 1 dose every 6 months 
        • 50-74 years: 1 dose every 12 months 
    • Influenza
      • For both Non-Aboriginal and Aboriginal: Every year (late March - April)
    • Shingles (2 doses of Shingrix® 2-6 months apart)
      • Non - Aboriginal: 50 years and older (free under the NIP for people 65 years and older)
      • Aboriginal: 50 years and older (free under the NIP)
    • Pneumococcal (1 dose of Capvaxive®)***
      • Non - Aboriginal: 65 years and older
      • Aboriginal: 25 years and older
    • RSV% (1 dose of Arexvy®)
      • Non-Aboriginal: 75 years and older
      • Aboriginal: 60 years and older

    * The vaccines can be co-administered (given at the same time).
    ** Vaccine can be given regardless of when the last COVID-19 infection was.
    ***Adults aged 65 years and older who have previously received any other pneumococcal vaccine are recommended and eligible to receive a dose of Capvaxive® at least 12 months after their last dose for free under the National Immunisation Program. Adults aged 18 to 64 years who receive Capvaxive® because of a specified medical risk condition do not need another dose at 65 years of age. ​​

    Home care service providers can use the resources below to discuss the infections and benefits of vaccination with clients and their families:


  • ​

    Staff and participants should not attend if they have tested positive to respiratory viruses, have any acute respiratory or influenza-like symptoms, or have been in close contact with someone who has a respiratroy virus​​.

    In arranging activities, day program providers should:

    • encourage all staff and volunteers to be fully vaccinated
    • encourage everyone to wear a mask where appropriate, based on an internal risk assessment
    • hold events outdoors or consider the guidance in maximising natural or mechanical ventilation
    • have respiratory virus occupational health and safety plans in place.​
  • ​

    The Australian Government Department of Health and Aged Care has issued a Guide for Home Care Providers to assist staff in reducing the risk of acute respiratory infections.

    Please seek the advice of your local NSW Health Public Health Unit if you have questions about how to appropriately mitigate risk when providing home care services on 1300 066 055.

    For more information about NDIS-related issues, including any funding issues relating to compliance with these measures for NDIS participants, contact:

Current as at: Thursday 1 October 2026